Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/2013
04/25/2013US20130102548 Pharmaceutical delivery system
04/25/2013US20130102545 Temperature dependent activation of catalytic nucleic acids for controlled active substance release
04/25/2013US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor
04/25/2013US20130101671 Polypeptide for treating or preventing adhesions
04/25/2013US20130101626 Mucin antigen vaccine
04/25/2013US20130101565 Use of carbonic anhydrase ii for producing a drug
04/25/2013US20130101558 Aav-based treatment of cholesterol-related disorders
04/25/2013US20130101510 Methods of treating parkinson's disease using viral vectors
04/25/2013CA2852960A1 Antigen presenting cancer vaccine with gamma interferon
04/24/2013EP2583693A1 Pharmaceutical composition utilizing pancreatic cell proliferation factor
04/24/2013EP2583692A1 Inhibitor of expression of dominant allele
04/24/2013EP2583691A1 Agent for treating renal fibrosis
04/24/2013EP2582796A2 Modified parvovirus having enhanced anti-tumour efficacy
04/24/2013EP2582399A2 Reprogramming cancer cells
04/24/2013EP2582396A2 Long lasting drug formulations
04/24/2013EP2582379A2 Compositions and methods for the treatment of atherosclerosis
04/24/2013CN1788017B Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions
04/24/2013CN1552734B Recombination glant associated virus carrier induced TNF concerned cytonecrosis ligand peptide fragment and its use
04/24/2013CN1520303B Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
04/24/2013CN103068982A Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
04/24/2013CN103068971A Reprogramming cancer cells
04/24/2013CN103068402A Composition for regeneratng normal tissue from fibrotic tissue
04/24/2013CN103060377A Lentiviral vector of pseudotyped lymphocytic choriomeningitis virus glycoprotein
04/24/2013CN103060357A Expression vector containing bone morphogenetic protein (BMP) gene and building method and application thereof
04/24/2013CN103060356A Duck plague virus deficient in g E gene transfer vector and constructing method thereof
04/24/2013CN103060331A Preparation method and application of capsid-protein-mutant double-stranded recombinant adeno-associated virus containing mediated-membrane-stabile CD40L gene
04/24/2013CN103060325A Antisense nucleic acid and peptide nucleic acid PNA resisting against porcine epidemic diarrhea virus PEDV
04/24/2013CN103060324A Multiple promoter expression cassettes for simultaneous delivery of rnai agents
04/24/2013CN103060323A Antisenseoligonuclleotide and application of antisenseoligonuclleotide in preparation of medicament for treating gastric cancer
04/24/2013CN103060316A Preparation method and application of target human nucleolar protein hRrp15esiRNA
04/24/2013CN103060278A Asia 1 type foot and mouth disease virus acid resistant mutant strains, capsid protein carried by same and encoding gene thereof and application
04/24/2013CN103059104A Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
04/24/2013CN103055326A Application of TCRP1 gene in the preparation of tumor cell platinum resistance reversal agent
04/24/2013CN103055325A Specific gene-virus therapeutic drug for colorectal cancer
04/24/2013CN103055314A 雌激素的应用 Application of estrogen
04/24/2013CN103055308A Male DNA (Deoxyribonucleic Acid) contraceptive vaccine
04/24/2013CN102525926B Propylene glycol amine derivate cationic liposome nano particles and preparation method thereof
04/24/2013CN102382823B Human miR-515-5p antisense oligod-eoxynucleotide and applications thereof
04/24/2013CN102337268B Human CTRP4 gene, its coding protein and their application
04/24/2013CN102240404B Vibrio harveyi DNA vaccine and its construction method and application
04/24/2013CN102212520B Small interfering RNA (siRNA) sequence for specifically silencing chicken Marek's disease virus gI and gE genes, vectors and application thereof
04/24/2013CN101905018B Recombinant fusion protein vaccine and attenuated live vector vaccine for treating and preventing helicobacter pylori (Hp) infection
04/24/2013CN101643789B RNA interference mediating small RNA molecules
04/24/2013CN101555284B Truncated-type human ciliary nerve nutrition factor active segment and fusion protein thereof
04/24/2013CN101537015B Application of carbon nano-tubes in immunity accelerators for preparing anti-tumor immunotherapy medicaments
04/24/2013CN101300346B Novel biological substance nesfatin and its related substances and uses thereof
04/24/2013CN101182534B Circular DNA molecule having a conditional origin of replication, process for their preparation
04/23/2013US8426592 Histone deacetylases, and uses related thereto
04/23/2013US8426379 POT1 alternative splicing variants
04/23/2013US8426377 iRNA agents with biocleavable tethers
04/23/2013US8426375 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
04/23/2013US8426374 Method for modifying myostatin expression
04/23/2013US8426205 Method for selective electrofusion of at least two fusion partners having cell-like membranes
04/23/2013US8426130 Methods of diagnosing alzheimer's disease and markers identified by set association
04/23/2013US8426124 Providing a host cell that has been infected by a virus and cultivating the host cell at two different temperatures to obtain high titer and improved purity; culturing
04/23/2013US8426028 Preparation of sensors on oligo- or poly (ethylene glycol) films on silicon surfaces
04/23/2013US8425876 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof
04/23/2013CA2523138C Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
04/23/2013CA2494764C Treatment of melanoma by reduction in clusterin levels
04/23/2013CA2475102C Stabilized synthetic immunogen delivery systems
04/23/2013CA2473212C Pharmaceutical composition which improves in vivo gene transfer
04/23/2013CA2458394C Lipophilic drug compositions
04/23/2013CA2400838C Novel method for down-regulation of amyloid
04/23/2013CA2377107C Delivery of trefoil peptides
04/18/2013WO2013056264A2 Systems and methods for predicting response to anti-androgen therapy for the treatment of androgenetic alopecia
04/18/2013WO2013056248A2 Treatment of breast cancer with companion diagnostic
04/18/2013WO2013056132A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
04/18/2013WO2013056105A2 INHIBITION OF SPINAL MAMMALIAN TARGET OF RAPAMYCIN (mTOR) REDUCES CANCER PAIN, OPIOID TOLERANCE, AND HYPERALGESIA
04/18/2013WO2013055595A1 Determining responsiveness of autoimmune patients to dmard treatment
04/18/2013WO2013055420A2 Novel clostridium difficile dna vaccine
04/18/2013WO2013055418A2 Cross-protective arenavirus vaccines and their method of use
04/18/2013WO2013054123A1 Methods
04/18/2013WO2013022991A3 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer
04/18/2013US20130096370 Compositions and systems for the regulation of genes
04/18/2013US20130096182 Recombinant adeno-associated vectors for targeted treatment
04/18/2013US20130096180 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
04/18/2013US20130095569 Pregnancy-associated plasma protein-a2 (papp-a2) polynucleotides
04/18/2013US20130095549 Tweak receptor
04/18/2013US20130095482 Methods of detecting pregnancy-associated plasma protein-a2 (papp-a2)
04/18/2013US20130095475 Genes from the 20q13 amplicon and their uses
04/18/2013US20130095089 Glucosylceramide synthase inhibitors and therapeutic methods using the same
04/18/2013CA2852064A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
04/18/2013CA2851284A1 Treatment of breast cancer with companion diagnostic
04/18/2013CA2850145A1 Methods
04/17/2013EP2580325A2 Retrovirus detection
04/17/2013EP2579900A1 Vectors and sequences for the treatment of diseases
04/17/2013EP2579885A1 Parvovirus for treatment of tumours by intranasal application
04/17/2013CN1854300B Recombinant plasmid containing PON gene and its use
04/17/2013CN103052397A Adenovirus AD36 E4ORF1 protein for prevention and treatment of non-alcoholic fatty liver disease
04/17/2013CN103045646A Recombinant adeno-associated virus vector for co-expression of two independent anti-arthritis molecules TNFR-Fc and CTLA4-FasL, as well as construction method and application of recombinant adeno-associated virus vector
04/17/2013CN103045634A Cationic liposome compound of cancer suppressor gene LKB1 eukaryotic expression plasmid as well as preparation method and anti-tumor effect thereof
04/17/2013CN103045630A Encephalitis virus protein and encoding gene and application thereof
04/17/2013CN103045597A Small nucleotide hsa-miR-1909 and application thereof
04/17/2013CN103045595A Antisense oligonucleotide for restraining expression of human hPEBP4 (Phosphatidyl Ethanolamine Binding Family Protein) gene and application thereof
04/17/2013CN103045592A Long-chain non-encoding nucleic acid segment related with duplication of flu viruses and application thereof
04/17/2013CN103045545A Encephalitis virus protein, and coding gene and application thereof
04/17/2013CN103045544A Recombinant pseudotyped baculovirus Bac-G-prM/E for preventing West Nile virus as well as vaccine and application thereof
04/17/2013CN103045540A Novel method for promoting bone mesenchymal stem cells to be differentiated into neurons in rat brain
04/17/2013CN103041404A Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine
04/17/2013CN102416183B Application of micro ribose nucleic acid (RNA) (miR)-297b
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 870